Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

A small-molecule inhibitor of C5 complement protein

This article has been updated

Abstract

The complement pathway is an important part of the immune system, and uncontrolled activation is implicated in many diseases. The human complement component 5 protein (C5) is a validated drug target within the complement pathway, as an anti-C5 antibody (Soliris) is an approved therapy for paroxysmal nocturnal hemoglobinuria. Here, we report the identification, optimization and mechanism of action for the first small-molecule inhibitor of C5 complement protein.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Small-molecule interaction with C5 complement protein.
Fig. 2: Mechanism of action of C5 small-molecule inhibitors.

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article (and its supplementary files). The cryo-EM map is available from the Electron Microscopy Data Bank with accession code EMD-4401. The atomic model has been deposited in the Protein Data Bank with the accession code 6I2X.

Change history

  • 26 July 2019

    In the version of this article originally published, numbered compounds were not linked correctly to their respective compound pages. The error has been corrected in the HTML version of this paper.

References

  1. Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J. D. Nat. Immunol. 11, 785–797 (2010).

    Article  CAS  Google Scholar 

  2. Walport, M. J. N. Engl. J. Med. 344, 1058–1066 (2001).

    Article  CAS  Google Scholar 

  3. Ricklin, D., Barratt-Due, A. & Mollnes, T. E. Mol. Immunol. 89, 10–21 (2017).

    Article  CAS  Google Scholar 

  4. Zhang, M. et al. ACS Med. Chem. Lett. 3, 317–321 (2012).

    Article  Google Scholar 

  5. Volz, C. & Pauly, D. Eur. J. Pharm. Biopharm. 95, 158–172 (2015).

    Article  CAS  Google Scholar 

  6. Laursen, N. S. et al. EMBO J. 30, 606–616 (2011).

    Article  CAS  Google Scholar 

  7. Nishimura, J. et al. N. Engl. J. Med. 370, 632–639 (2014).

    Article  CAS  Google Scholar 

  8. Fredslund, F. et al. Nat. Immunol. 9, 753–760 (2008).

    Article  CAS  Google Scholar 

  9. Laursen, N. S. et al. Proc. Natl Acad. Sci. USA 107, 3681–3686 (2010).

    Article  CAS  Google Scholar 

  10. Jore, M. M. et al. Nat. Struct. Mol. Biol. 23, 378–386 (2016).

    Article  CAS  Google Scholar 

  11. Seelen, M. A. et al. J. Immunol. Methods 296, 187–198 (2005).

    Article  CAS  Google Scholar 

  12. Maibaum, J. et al. Small-molecule factor D inhibitors targeting the alternative complement pathway. Nat. Chem Biol. 12, 1105–1110 (2016).

    Article  CAS  Google Scholar 

  13. Salcius, M. et al. J. Biomol. Screen. 19, 917–927 (2014).

    Article  Google Scholar 

  14. Niesen, F. H., Berglund, H. & Vedadi, M. Nat. Protoc. 2, 2212–2221 (2007).

    Article  CAS  Google Scholar 

  15. An, J., Totrov, M. & Abagyan, R. Mol. Cell Proteomics 4, 752–761 (2005).

    Article  CAS  Google Scholar 

  16. Zhou, L., Yang, L., Tilton, S. & Wang, J. J. Pharm. Sci. 96, 3052–3071 (2007).

    Article  CAS  Google Scholar 

  17. Molecular Operating Environment (MOE) v.2013.08 (Chemical Computing Group ULC, 2018).

  18. Zheng, S. Q. et al. Nat. Methods 14, 331–332 (2017).

    Article  CAS  Google Scholar 

  19. Scheres, S. H. J. Struct. Biol. 180, 519–530 (2012).

    Article  CAS  Google Scholar 

  20. Grant, T., Rohou, A. & Grigorieff, N. eLife 7, e35383 (2018).

  21. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Acta Crystallogr D 66, 486–501 (2010).

    Article  CAS  Google Scholar 

  22. Adams, P. D. et al. Acta Crystallogr D 66, 213–221 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

M. Salcius and D.M. performed the biophysical binding assays to identify and qualify C5 as the target. A. Nguyen produced the recombinant C5 protein variants and the C5–CVF complex. A.D.E. performed complement functional assays on human whole blood, sera of different species and mutant C5 proteins and analyzed the data. L.F. and J.H. performed assays to identify the target of the compound described in the literature and analyzed the data. F.L. screened C5 inhibitors in a serum-based complement assay. K.J., P.B., A. Namil, M.C., V.D., E.M. and N.M. designed C5 inhibitors. K.J., P.B., A. Namil, M.C., V.D. and R.T. synthesized compounds. K.J., M.K., P.B. and J.D. conceived and carried out molecular modeling studies. P.A.H. and M.J.R. performed the X-ray crystallization experiments. M.K. identified potential binding pockets. N.M. and M.M. proposed the idea to identify the target of the complement inhibitor. J.M. and M. Schirle designed and analyzed the C5-protease-sensitivity assays. H.S., C.B. and C.W. determined the cryo-EM structure. K.A., K.J., M.K. and G.A.M. conceived experiments, supervised the work and wrote the manuscript.

Corresponding author

Correspondence to Gregory A. Michaud.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Tables 1–6, Supplementary Figures 1–5

Reporting Summary

Supplementary Note 1

Synthetic procedures

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jendza, K., Kato, M., Salcius, M. et al. A small-molecule inhibitor of C5 complement protein. Nat Chem Biol 15, 666–668 (2019). https://doi.org/10.1038/s41589-019-0303-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-019-0303-9

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research